Insider Selling: Omada Health (NASDAQ:OMDA) CEO Sells $650,696.20 in Stock

Omada Health, Inc. (NASDAQ:OMDA) CEO Sean Duffy sold 40,796 shares of the firm’s stock in a transaction that occurred on Tuesday, January 13th. The stock was sold at an average price of $15.95, for a total transaction of $650,696.20. Following the transaction, the chief executive officer directly owned 126,644 shares in the company, valued at approximately $2,019,971.80. This trade represents a 24.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link.

Omada Health Stock Performance

Shares of NASDAQ OMDA opened at $16.12 on Friday. Omada Health, Inc. has a 52-week low of $14.14 and a 52-week high of $28.40. The firm has a market capitalization of $933.48 million and a price-to-earnings ratio of -64.48. The stock has a 50 day moving average price of $16.86 and a 200 day moving average price of $19.96.

Analyst Upgrades and Downgrades

OMDA has been the subject of a number of research reports. Barclays lowered their price objective on shares of Omada Health from $29.00 to $22.00 and set an “overweight” rating for the company in a research note on Monday, January 5th. Needham & Company LLC increased their price objective on shares of Omada Health from $26.00 to $28.00 and gave the company a “buy” rating in a research note on Friday, November 7th. Wells Fargo & Company initiated coverage on Omada Health in a research report on Thursday, January 8th. They issued an “equal weight” rating and a $17.00 price target for the company. Morgan Stanley set a $32.00 price target on shares of Omada Health in a research report on Thursday, December 18th. Finally, Evercore ISI lifted their price objective on shares of Omada Health from $27.00 to $28.00 and gave the stock an “outperform” rating in a research report on Friday, November 7th. Eight analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $25.10.

Institutional Investors Weigh In On Omada Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Cigna Investments Inc. New acquired a new stake in Omada Health in the third quarter worth about $76,161,000. Perceptive Advisors LLC acquired a new stake in Omada Health in the 2nd quarter worth approximately $44,402,000. Divisadero Street Capital Management LP purchased a new stake in Omada Health during the 3rd quarter worth approximately $30,510,000. Loomis Sayles & Co. L P acquired a new position in Omada Health during the 2nd quarter valued at approximately $19,948,000. Finally, BIT Capital GmbH acquired a new stake in shares of Omada Health during the third quarter worth $13,639,000.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.